Please use this identifier to cite or link to this item:
Title: The NUTRAOLEOUM Study, a randomized controlled trial, for achieving nutritional added value for olive oils.
Authors: Biel, Sara
Mesa, Maria-Dolores
de la Torre, Rafael
Espejo, Juan-Antonio
Fernández-Navarro, Jose-Ramón
Fitó, Montserrat
Sánchez-Rodriguez, Estefanía
Rosa, Carmen
Marchal, Rosa
Alche, Juan de Dios
Expósito, Manuela
Brenes, Manuel
Gandul, Beatriz
Calleja, Miguel Angel
Covas, María-Isabel
Keywords: Functional olive oil;Maslinic acid;Oleanolic acid;Olive oil;Olive oil polyphenols;Virgin olive oil
metadata.dc.subject.mesh: Adult
DNA Damage
Functional Food
Lipid Metabolism
Middle Aged
Olive Oil
Young Adult
Issue Date: 22-Oct-2016
Abstract: Virgin olive oil, a recognized healthy food, cannot be consumed in great quantities. We aim to assess in humans whether an optimized virgin olive oil with high phenolic content (OVOO, 429 mg/Kg) and a functional one (FOO), both rich in phenolic compounds (429 mg/Kg) and triterpenic acids (389 mg/kg), could provide health benefits additional to those supplied a by a standard virgin olive oil (VOO). A randomized, double-blind, crossover, controlled study will be conducted. Healthy volunteers (aged 20 to 50) will be randomized into one of three groups of daily raw olive oil consumption: VOO, OVOO, and FOO (30 mL/d). Olive oils will be administered over 3-week periods preceded by 2-week washout ones. The main outcomes will be markers of lipid and DNA oxidation, inflammation, and vascular damage. A bioavailability and dose-response study will be nested within this sustained- consumption one. It will be made up of 18 volunteers and be performed at two stages after a single dose of each olive oil. Endothelial function and nitric oxide will be assessed at baseline and at 4 h and 6 h after olive oil single dose ingestion. For the first time the NUTRAOLEUM Study will provide first level evidence on the health benefits in vivo in humans of olive oil triterpenes (oleanolic and maslinic acid) in addition to their bioavailability and disposition. The Trial has been registered in ID: NCT02520739 .
metadata.dc.identifier.doi: 10.1186/s12906-016-1376-6
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5075414.pdf500,56 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons